Both in Pharmaceuticals
Royalty Pharma vs Roivant Sciences
Over the past year RPRX returned +65.2% and ROIV returned +141.7%; their daily moves had a correlation of 0.10.
RPRX +65.2% ROIV +141.7%Growth of $1, one year, split-adjusted
| Metric | RPRX | ROIV |
|---|---|---|
| Price | $58.22 | $36.50 |
| Market cap | $25.92B | $26.36B |
| Today | −0.26% | −1.30% |
| 1 month | −4.3% | +5.2% |
| 6 months | +25.6% | +38.2% |
| Year to date | +50.7% | +68.2% |
| 1 year | +66.2% | +140.6% |
| Revenue growth (YoY) | +16.5% | −33.5% |
| Gross margin | 100.0% | 100.0% |
| Net margin | 2.7% | −13164.8% |
| P/E (TTM) | 31.8× | — |
| Price / sales | 10.2× | 3,500.4× |
| Net cash | -$8.23B | $3.84B |
| Dividend yield | 1.61% | — |
| Volatility (60d) | 24.0% | 49.4% |
| Short % of float | 2.7% | 9.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).